Trial Profile
GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Gadobutrol (Primary)
- Indications Breast cancer; Vascular disorders
- Focus Adverse reactions
- Acronyms GARDIAN
- Sponsors Bayer
- 06 Apr 2017 New trial record